OBESITY EFFECTS ON NITRAZEPAM DISPOSITION

被引:19
作者
ABERNETHY, DR
GREENBLATT, DJ
LOCNISKAR, A
OCHS, HR
HARMATZ, JS
SHADER, RI
机构
[1] BAYLOR COLL MED,HYPERTENS CLIN PHARMACOL SECT,HOUSTON,TX 77030
[2] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111
[3] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER
关键词
D O I
10.1111/j.1365-2125.1986.tb02934.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:551 / 557
页数:7
相关论文
共 22 条
  • [1] THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM
    ABERNETHY, DR
    GREENBLATT, DJ
    DIVOLL, M
    SMITH, RB
    SHADER, RI
    [J]. CLINICAL PHARMACOKINETICS, 1984, 9 (02) : 177 - 183
  • [2] ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
  • [3] ARENDT RM, 1983, J PHARMACOL EXP THER, V227, P98
  • [5] DAWSON GW, 1982, PHARMACOL THERAPEUT, V15, P207
  • [6] CIMETIDINE IMPAIRS ELIMINATION OF CHLORDIAZEPOXIDE (LIBRIUM) IN MAN
    DESMOND, PV
    PATWARDHAN, RV
    SCHENKER, S
    SPEEG, KV
    [J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (02) : 266 - 268
  • [7] GREENBLATT DJ, 1983, NEW ENGL J MED, V309, P354
  • [8] GREENBLATT DJ, 1983, NEW ENGL J MED, V309, P410
  • [9] AGE, SEX, AND NITRAZEPAM KINETICS - RELATION TO ANTIPYRINE DISPOSITION
    GREENBLATT, DJ
    ABERNETHY, DR
    LOCNISKAR, A
    OCHS, HR
    HARMATZ, JS
    SHADER, RI
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) : 697 - 703
  • [10] HOLM V, 1982, Drug-Nutrient Interactions, V1, P307